Treatment of essential thrombocythemia with anagrelide. A ten-year experience

Medicina

Volumn 62, Issue 3, 2002, Pages 231-236

  Kornblihtt, Laura I ^a   Vassallu, Patricia S ^a   Heller, Paula ^a   Molinas, Felisa C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anagrelide; Essential thrombocythemia

Indexed keywords

ALPHA INTERFERON; ANAGRELIDE; BUSULFAN; HYDROXYUREA; PHOSPHORUS 32; ANTITHROMBOCYTIC AGENT; QUINAZOLINE DERIVATIVE;

ABDOMINAL DISTENSION; ADULT; ANEMIA; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CELL MATURATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; EDEMA; FEMALE; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELOFIBROSIS; NAUSEA; SYMPTOMATOLOGY; THROMBOCYTE COUNT; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADOLESCENT; AGED; BLOOD; CHILD; MIDDLE AGED; THROMBOCYTHEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; QUINAZOLINES; THROMBOCYTHEMIA, HEMORRHAGIC; TREATMENT OUTCOME;

EID: 0036324504     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Anagrelide: A new drug for treating thrombocytosis
2. Anagrelide: A potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity
3. Effect of Anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders
4. The effects of Anagrelide on human megakaryocytopoiesis
5. Analysis of the mecanism of Anagrelide-induced thrombocytopenia in humans
6. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders
7. Essential thrombocythemia: An interin report for de Polycythemia Vera Study Group
8. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival and leukemic transition by treatment
9. BCR-ABL transcripts may be detected in essential thrombocythemia but lack clinical significance
10. Evaluation of inherited and acquired thrombophilia defects in essential thrombocythemia
11. Effectiveness of Anagrelide in the treatment of symptomatic patients with essential thrombocythemia
12. 2 y factor de crecimiento derivado de las plaquetas en la trombocitemia esencial tratada con anagrelide
13. Primary thrombocythemia: Diagnosis, clinical manifestations and management
14. Thombo-haemorragic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and function
15. Hydroxiurea for patients with essential thrombocythemia and high risk of thrombosis
16. No treatment for low-risk thrombocythaemia: Results from a prospective study
17. Thrombotic complications in essential thrombocythemia with relatively low platelet counts